News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
232,872 Results
Type
Article (5239)
Company Profile (24)
Press Release (227609)
Multimedia
Podcasts (3)
Webinars (4)
Section
Business (82446)
Career Advice (464)
Deals (15092)
Drug Delivery (11)
Drug Development (19144)
Employer Resources (30)
FDA (3731)
Job Trends (3933)
News (120541)
Policy (7568)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (296)
Accelerated approval (6)
Adcomms (4)
Allergies (14)
Alliances (14898)
ALS (38)
Alzheimer's disease (296)
Antibody-drug conjugate (ADC) (44)
Approvals (3831)
Artificial intelligence (82)
Autoimmune disease (27)
Automation (5)
Bankruptcy (97)
Best Places to Work (2881)
Biosimilars (78)
Biotechnology (23)
Bladder cancer (34)
Brain cancer (7)
Breast cancer (102)
Cancer (894)
Cardiovascular disease (63)
Career advice (396)
Career pathing (3)
CAR-T (64)
CDC (2)
Cell therapy (166)
Cervical cancer (5)
Clinical research (16742)
Collaboration (362)
Compensation (371)
Complete response letters (8)
COVID-19 (314)
CRISPR (13)
C-suite (341)
Cystic fibrosis (28)
Data (1331)
Denatured (1)
Depression (21)
Diabetes (78)
Diagnostics (2128)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (32)
Drug pricing (23)
Drug shortages (2)
Duchenne muscular dystrophy (35)
Earnings (42791)
Editorial (5)
Employer branding (6)
Employer resources (32)
Events (39229)
Executive appointments (427)
FDA (4473)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (341)
Gene editing (24)
Generative AI (5)
Gene therapy (102)
GLP-1 (145)
Government (433)
Guidances (198)
Healthcare (5075)
HIV (10)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (43)
Immuno-oncology (7)
Indications (16)
Infectious disease (341)
Inflammatory bowel disease (37)
Inflation Reduction Act (5)
Influenza (6)
Intellectual property (34)
Interviews (53)
IPO (7900)
IRA (5)
Job creations (1130)
Job search strategy (362)
JPM (4)
Kidney cancer (10)
Labor market (10)
Layoffs (108)
Leadership (5)
Legal (2348)
Liver cancer (21)
Longevity (2)
Lung cancer (95)
Lymphoma (70)
Machine learning (3)
Management (10)
Manufacturing (151)
MASH (50)
Medical device (3942)
Medtech (3952)
Mergers & acquisitions (7599)
Metabolic disorders (215)
Multiple sclerosis (19)
NASH (6)
Neurodegenerative disease (54)
Neuropsychiatric disorders (12)
Neuroscience (542)
NextGen: Class of 2026 (1681)
Non-profit (731)
Now hiring (5)
Obesity (85)
Opinion (35)
Ovarian cancer (26)
Pain (27)
Pancreatic cancer (38)
Parkinson's disease (50)
Partnered (6)
Patents (54)
Patient recruitment (96)
Peanut (6)
People (25258)
Pharmaceutical (7)
Pharmacy benefit managers (4)
Phase 1 (5014)
Phase 2 (7247)
Phase 3 (5818)
Pipeline (1974)
Policy (22)
Postmarket research (628)
Preclinical (1948)
Press Release (66)
Prostate cancer (58)
Psychedelics (3)
Radiopharmaceuticals (110)
Rare diseases (180)
Real estate (1897)
Recruiting (8)
Regulatory (5578)
Reports (17)
Research institute (312)
Resumes & cover letters (69)
Rett syndrome (19)
RNA editing (1)
RSV (2)
Schizophrenia (49)
Series A (53)
Series B (54)
Sickle cell disease (10)
Special edition (1)
Spinal muscular atrophy (33)
Sponsored (5)
Startups (1023)
Stomach cancer (1)
Supply chain (14)
Tariffs (7)
The Weekly (2)
Vaccines (82)
Venture capital (9)
Weight loss (30)
Women's health (6)
Date
Today (4)
Last 7 days (148)
Last 30 days (620)
Last 365 days (8955)
2026 (791)
2025 (9085)
2024 (11115)
2023 (13258)
2022 (18751)
2021 (19763)
2020 (18338)
2019 (13284)
2018 (10276)
2017 (10057)
2016 (9220)
2015 (12166)
2014 (9608)
2013 (7722)
2012 (8341)
2011 (8806)
2010 (8637)
Location
Africa (186)
Alabama (19)
Alaska (2)
Arizona (74)
Arkansas (1)
Asia (12121)
Australia (1695)
California (3549)
Canada (1140)
China (170)
Colorado (143)
Connecticut (162)
Delaware (71)
Europe (25591)
Florida (541)
Georgia (67)
Idaho (24)
Illinois (164)
India (14)
Indiana (105)
Iowa (9)
Japan (165)
Kansas (36)
Kentucky (17)
Louisiana (8)
Maine (51)
Maryland (355)
Massachusetts (2805)
Michigan (104)
Minnesota (201)
Mississippi (1)
Missouri (32)
Montana (17)
Nebraska (12)
Nevada (46)
New Hampshire (16)
New Jersey (1022)
New Mexico (5)
New York (815)
North Carolina (479)
North Dakota (4)
Northern California (1858)
Ohio (116)
Oklahoma (5)
Oregon (6)
Pennsylvania (597)
Puerto Rico (1)
Rhode Island (19)
South America (279)
South Carolina (17)
Southern California (1307)
Tennessee (61)
Texas (482)
United States (12359)
Utah (112)
Virginia (84)
Washington D.C. (18)
Washington State (299)
West Virginia (2)
Wisconsin (58)
Wyoming (1)
232,872 Results for "samsung corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Samsung Biologics receives EcoVadis Platinum, the highest sustainability rating
January 28, 2026
·
3 min read
Press Releases
Samsung Epis Holdings Reports Fourth Quarter and Fiscal Year 2025 Financial Results
January 26, 2026
·
6 min read
Press Releases
CEPI and Samsung Biologics collaborate to strengthen outbreak-ready vaccine production and global access
February 3, 2026
·
6 min read
Press Releases
Samsung Bioepis Announces Approval of Ustekinumab Biosimilar in Japan
December 23, 2025
·
2 min read
Press Releases
Samsung Biologics reports fourth quarter and fiscal year 2025 financial results
January 21, 2026
·
5 min read
Press Releases
Samsung Bioepis Begins Commercialization of BYOOVIZ®, Biosimilar to Lucentis (Ranibizumab), in Europe
January 5, 2026
·
2 min read
Press Releases
Newly Established Samsung Epis Holdings to Drive Growth for Samsung Bioepis and a New Subsidiary
November 3, 2025
·
3 min read
Press Releases
Samsung Epis Holdings Delivers Business Updates at the 44th J.P. Morgan Healthcare Conference
January 15, 2026
·
5 min read
Press Releases
Samsung Bioepis Releases First Quarter 2026 US Biosimilar Market Report, Providing Updates to Evolving Drug Pricing Models
January 26, 2026
·
2 min read
Press Releases
Samsung Bioepis Announces Launch of Denosumab Biosimilars, OBODENCE™ and XBRYK™, in Europe
December 1, 2025
·
5 min read
1 of 23,288
Next
